Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration

被引:64
|
作者
Lornoy, W
Becaus, I
Billiouw, JM
Sierens, L
van Malderen, P
机构
[1] OL Vrouwziekenhuis, Renal Unit, B-9300 Aalst, Belgium
[2] OL Vrouwziekenhuis, Cent Lab, B-9300 Aalst, Belgium
关键词
beta-2-microglobulin; hemodiafiltration; dialysis-related amyloidosis; high-flux hemodialysis membranes;
D O I
10.1159/000013317
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Eight chronic, anuric hemodialysis patients were randomly treated with a high-flux polysulphone dialyzer (F80), using 6 different modes: conventional bicarbonate hemodialysis (HD), hemodiafiltration (HDF) with a replacement solution at 40, 60, 80 or 100 ml/min in postdilution and 80 ml/min in predilution. The differences in beta(2)-microglobulin (beta 2M) reduction ratio and clearance were evaluated statistically by analysis of variance (ANOVA). Both studies revealed no significant difference between HD and HDF40 in postdilution, but an increasing significant difference from HDF60 to HDF100 in postdilution and with HDF80 in predilution. The mean reduction ratio ranged from 49.7 (HD) to 72.7% (HDF 100 ml/min), showing an overall statistically significant difference (p = 0.0000). For the clearance, the range was between 63.8 (HD) and 116.8 ml/min (HDF 100 ml/min) (p = 0.0000). beta 2M in the effluent dialysate with HDF100 ml/min reached up to a mean of 258 mg/session. Concerning small molecules (BUN, creatinine and P), there was a statistically significant different clearance for creatinine and especially for P with HDF 100 ml/min. Conclusion: HDF with an on-line replacement solution at 100 ml/min and a high-flux and biocompatible polysulphone membrane represents a new tool for enhanced removal of beta 2M. Besides a significant increase in creatinine and especially in phosphorus clearance is noted.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [31] BETA-2-MICROGLOBULIN AMYLOIDOSIS AND RENAL BONE-DISEASE
    DRUEKE, TB
    MINERAL AND ELECTROLYTE METABOLISM, 1991, 17 (04) : 261 - 272
  • [32] EVALUATION OF SERUM BETA-2-MICROGLOBULIN IN ORAL-CANCER
    MANZAR, W
    RAGHAVAN, MRV
    AROOR, AR
    KESHAVAMURTHY, KR
    AUSTRALIAN DENTAL JOURNAL, 1992, 37 (01) : 39 - 42
  • [33] AMYLOIDOSIS OF THE BETA-2-MICROGLOBULIN TYPE - A PROTEIN THESAUROSIS WITH OSTEOARTICULOPATHIES
    LINKE, RP
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1992, 21 (08) : 339 - 342
  • [34] Beta-2-microglobulin in chronic myelogenous leukemia: Preliminary results
    Bourantas, K
    Mavridis, A
    Tsiara, S
    Seferiadis, K
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1996, 15 (03) : 283 - 286
  • [35] Effects of alpha-interferon on serum beta-2-microglobulin
    Remes, K
    Tienhaara, A
    Pelliniemi, TT
    LEUKEMIA & LYMPHOMA, 1996, 21 (3-4) : 233 - 238
  • [36] Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy
    Kim, S.
    Oh, K. H.
    Chin, H. J.
    Na, K. Y.
    Kim, Y. S.
    Chae, D. -W.
    Ahn, C.
    Han, J. S.
    Kim, S.
    Joo, K. W.
    CLINICAL NEPHROLOGY, 2009, 72 (06) : 442 - 448
  • [37] On-line hemodiafiltration: Technique and therapy
    Ledebo, I
    ADVANCES IN RENAL REPLACEMENT THERAPY, 1999, 6 (02): : 195 - 208
  • [38] Albumin loss in on-line hemodiafiltration
    Combarnous, F
    Tetta, C
    Cellier, CC
    Wratten, ML
    Custaud, MA
    De Catheu, T
    Fouque, D
    David, S
    Carraro, G
    Laville, M
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (03) : 203 - 209
  • [39] Hemodiafiltration with on-line endogenous reinfusion
    de Francisco, ALM
    Piñera, C
    Heras, M
    Rodrigo, E
    Fresnedo, GF
    Ruiz, JC
    Tetta, C
    Arias, M
    BLOOD PURIFICATION, 2000, 18 (03) : 231 - 236
  • [40] Serum beta-2-microglobulin, TNF-α and interleukins in myeloproliferative disorders
    Bourantas, KL
    Hatzimichael, EC
    Makis, AC
    Chaidos, A
    Kapsali, ED
    Tsiara, S
    Mavridis, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 63 (01) : 19 - 25